Background Nationwide studies report the high incidence of major health outcomes following myocardial infarction (MI). This ...
Background Current guidelines recommend complete removal of a cardiac implantable electronic device (CIED) in patients with infective endocarditis (IE), although these recommendations are largely ...
Background Effective decongestion is a key therapeutic goal during hospitalisation for acute heart failure (HF), but the ...
Background Obesity is a major contributor to cardiovascular disease (CVD). Different fat depots may have distinct effects on ...
Background Pericarditis may be associated with significant morbidity and mortality and can be a clinically challenging entity ...
Pericarditis remains a clinical diagnosis. No single symptom, biomarker, electrocardiographic pattern or imaging finding is sufficiently sensitive and specific across the full spectrum of disease. The ...
Background Hypochloraemia has emerged as a prognostic marker in heart failure, although the mechanisms underlying chloride ...
Cancer therapy has dramatically changed over the past many decades, not only in efficacy but also complexity, with targeted therapeutics that have novel mechanisms of action. As a direct result of ...
Background Despite advances in acute coronary syndrome (ACS) management, contemporary data assessing long-term prognosis after ST-segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI) ...
Thoracic aortic aneurysm (TAA) is a relatively common, under-recognised and lethal condition. Yet, current management remains anchored on absolute diameter for prophylactic repair, despite many ...
For more than two decades, the crucial dilemma of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has remained unchanged: the same therapies used to treat myocardial ...
Background Shorter dual antiplatelet therapy (DAPT) regimens may offer a more favourable risk-benefit profile compared with longer treatment. The aim of this study was to determine the optimal ...